WHO ICTRP trial
A Phase II trial of haploidentical transplantation with high dose…
JPRN-UMIN000010316 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000010316 |
|---|---|
| Public title | A Phase II trial of haploidentical transplantation with high dose, post-transplantation cyclophosphamide. |
| Scientific title | A Phase II trial of haploidentical transplantation with high dose, post-transplantation cyclophosphamide. - JSCT-Haplo13 |
| Primary sponsor | JSCT |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | ALL,AML,MDS,CML,NHL,MM |
| Interventions | The preparative regimen will consist of : Fludarabine 30mg/m2 IV Days -6, -5, -4, -3, -2 Cyclophosphamide 14.5mg/kg IV Days -6, -5 Busulfan 3.2mg/kg IV Days -3, -2 Total body irradiation (TBI) 2Gy Day -1 Day 0 will be the day of infusion of… |
| Registration date | Mar 26, 2013 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: